DocGo Inc. (DCGO)

NasdaqCM: DCGO · 실시간 가격 · USD

0.71

+0.04 (5.97%)

종가 기준: Aug 17, 2026, 8:00 PM

5.97% (1D)

데이터 없음

매수호가	0.48
시가총액	70.14M
매출 (ttm)	301.71M
순이익 (ttm)	-187.76M
베타	0.99
EPS (ttm)	-1.9
P/E (ttm)	n/a
선행 P/E	13.95
P/B (ttm)	0.53
P/S (ttm)	0.23
Earnings Date	Aug 17, 2026

매도호가	0.87
거래량	1,644,536
평균 거래량 (20일)	772,653
시가	0.68
전일 종가	0.67
일중 범위	0.66 - 0.72
52주 범위	0.45 - 1.73
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

DCGO 소개

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are p...

[더 보기]

산업 Medical Care Facilities

섹터 Healthcare

IPO 일자 Dec 17, 2020

직원 수 2,537

상장 거래소 NasdaqCM

티커 DCGO

웹사이트 https://docgo.com

전체 기업 정보

재무 실적

2025년 DocGo의 매출은 322.2M로, 전년 616.56M 대비 -47.74% 감소했습니다. 순이익은 -182.4M로, -1,012.36% 감소했습니다.

재무제표

어닝 서프라이즈

DocGo가 Aug 17, 2026에 분기 실적을 발표했습니다:

매출 $75.55M 예상치 하회 $0, 및 -21.33% 전년 대비 감소.

EPS -0.26 예상치 하회 -0.11, 및 -23.81% 전년 대비 감소.

뉴스

1일 전 · MarketBeat

DocGo Q2 Earnings Call Highlights

DocGo (NASDAQ:DCGO) reported second-quarter revenue of $73.4 million, down from $80.4 million a year earlier, as the company continued to wind down migrant-related projects. Excluding migrant-related ...

1일 전 · Zacks

DocGo Inc. (DCGO) Surpasses Q2 Earnings Estimates

Motion Acquisition (DCGO) delivered earnings and revenue surprises of +500.00% and -2.28%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

5일 전 · Zacks

Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates

Lifeward (LFWD) delivered earnings and revenue surprises of +2.01% and -10.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

5일 전 · Zacks

Assembly Biosciences (ASMB) Reports Q2 Loss, Beats Revenue Estimates

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +71.43% and +45.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2주 전 · Zacks

Strength Seen in Surgery Partners (SGRY): Can Its 5.3% Jump Turn into More Strength?

Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price inc...

2 페이지 중 1

DocGo Inc. (DCGO)

DCGO 소개